COVID-19

An Examination of School Reopening Strategies during the SARS-CoV-2 Pandemic | Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience | Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors

An Examination of School Reopening Strategies during the SARS-CoV-2 Pandemic | Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience | Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 | The Impact of COVID Vaccination on Symptoms of Long COVID. An International Survey of People with Lived Experience of Long COVID | Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern | Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines | Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial | Efficacy of Portable Air Cleaners and Masking for Reducing Indoor Exposure to Simulated Exhaled SARS-CoV-2 Aerosols — United States, 2021

Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic | By Now, Burnout Is a Given | Confronting Our Next National Health Disaster — Long-Haul Covid | Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants |

Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials
Azithromycin (AZM) is commonly used in Covid-19 patients based on low-quality evidence, increasing the risk of developing adverse events and antimicrobial resistance.

Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

Illness duration and symptom profile in a large cohort of symptomatic UK school-aged children tested for SARS-CoV-2 | Pfizer-BioNTech COVID-19 Vaccine Storage and Handling Summary | Coronavirus (COVID-19) Update: FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19

Characteristics of COVID-19 Cases and Outbreaks at Childcare Facilities | Extended interval BNT16b2 vaccination enhances peak antibody generation in older people | Risk of SARS-CoV-2 reinfection in a university student population | Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection

An Examination of School Reopening Strategies during the SARS-CoV-2 Pandemic | Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience | Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors

Children make up nearly 21% of new COVID-19 cases | Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients | Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak |